Researchers continue to explore how ketamine works so quickly to relieve symptoms of depression and other stress-related mental health conditions. A new study highlights an important piece of the puzzle: ketamine changes functional connectivity in the brain, particularly in an area called the pregenual anterior cingulate cortex (pgACC). This brain region plays a key role in emotional processing and memory.
The study also looked at how lamotrigine, a drug that reduces glutamate release in the brain, might alter ketamine’s effects. Glutamate is a chemical messenger known to influence connectivity between brain areas. By pairing ketamine with lamotrigine, the researchers tested whether glutamate was driving the changes seen after ketamine treatment.
What the Study Found
In a controlled trial involving 75 healthy participants, researchers used functional MRI scans to track changes in brain activity. Participants were divided into three groups: one received ketamine, one received ketamine with lamotrigine, and the third received a placebo.
They found that:
- Ketamine alone increased connectivity between the pgACC and the dorsomedial prefrontal cortex during a working memory task.
- It also strengthened resting-state connectivity between the pgACC and the left insula, a region involved in emotional awareness.
- These effects disappeared when participants were pre-treated with lamotrigine, suggesting that glutamate release plays a major role in ketamine’s impact on the brain.
Why Functional Connectivity Ketamine Lamotrigine Research Matters
New Targets for Mood Disorders
Functional connectivity helps explain how different brain regions communicate. When connectivity improves in areas like the pgACC, people may experience better mood regulation and cognitive function. Ketamine appears to quickly enhance this connectivity, which might explain why it works faster than traditional antidepressants.
Glutamate’s Critical Role
This study reinforces that ketamine’s effects are closely tied to glutamate signaling, and that drugs like lamotrigine, which reduce glutamate, may blunt those benefits. This opens new possibilities for tailoring treatments based on how much a person’s brain relies on glutamate pathways.
Looking Ahead
This research offers insight into how psychedelic-assisted therapies like ketamine might work at the brain network level. Understanding these mechanisms could help guide future treatments for conditions like depression, PTSD, and anxiety—especially for those who haven’t responded to standard therapies.
Stay updated on Interventional Psychiatry with IPN.
Citations:
- Weigner D, Meiering MS, Weigand A, et al. Functional connectivity alterations of the pregenual anterior cingulate cortex by ketamine and the modulation by lamotrigine. J Psychopharmacol. 2024. https://journals.sagepub.com/doi/10.1177/02698811251346705
- Abdallah CG, Averill LA, Salas R, et al. Ketamine treatment and global brain connectivity in major depression. Neuropsychopharmacology. 2017; https://www.nature.com/articles/npp2016186